Cerebellum’s Nu Skin NUS Stock Holding History

Cerebellum’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,818	Closed	-$124K	–	517
2020 Q2	$124K	Buy	+1,818	New	+$58.4K	0.09%	274
2019 Q4	$417K	Hold	10,182	–	–	0.22%	310
2019 Q3	$433K	Buy	10,182 +2,843	+39%	+$119K	0.28%	220
2019 Q2	$362K	Buy	7,339 +393	+6%	+$20K	0.3%	38
2019 Q1	$332K	Buy	6,946 +2,677	+63%	+$162K	0.29%	139
2018 Q4	$262K	Buy	4,269 +2,417	+131%	+$163K	0.18%	71
2018 Q3	$153K	Sell	1,852 -327	-15%	-$26K	0.24%	317
2018 Q2	$170K	Sell	2,179 -443	-17%	-$34.3K	0.28%	253
2018 Q1	$193K	Buy	2,622 +804	+44%	+$57.1K	0.25%	66
2017 Q4	$124K	Buy	+1,818	New	+$118K	0.09%	274

Other funds holding NUS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Cerebellum's NUS Position: Q3 2020 in Review

Cerebellum sold out of Nu Skin (NUS) in Q3 2020, closing a stake of 1,818 shares — an estimated $124K sold.

Cerebellum first reported a position in NUS in Q4 2017 and held it in 10 quarters. The position peaked at $433K in Q3 2019. 251 funds tracked by Wall St. Rank hold NUS as of Q3 2020.

Cerebellum reported no remaining Nu Skin position as of Q3 2020 after selling out during the quarter.
Cerebellum sold 1,818 Nu Skin shares in Q3 2020, an estimated $124K.
Cerebellum first reported a position in Nu Skin in Q4 2017 and held it in 10 quarters.
Cerebellum's Nu Skin position peaked at $433K in Q3 2019.
251 funds tracked by Wall St. Rank held Nu Skin as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.